Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ASLAN Pharmaceuticals Limited (ASLN)

2.18   -0.32 (-12.8%) 01-24 16:00
Open: 2.5 Pre. Close: 2.5
High: 2.53 Low: 2.18
Volume: 465,885 Market Cap: 48M
ASLAN Pharmaceuticals Limited operates as a clinical-stage oncology and inflammatory disease focused biopharmaceutical company in the United States. It targets diseases that are prevalent in Asia, and orphan indications in the United States and Europe. The company's lead program, varlitinib, is a reversible small molecule pan-human epidermal growth factor receptor (HER), inhibitor that targets the human epidermal growth factor receptors HER1, HER2, and HER4, as well as gastric cancer. Its Varlitinib is currently being studied in a pivotal clinical trial for biliary tract cancer. In addition, the company is developing ASLAN003, an orally active potent inhibitor of human dihydroorotate dehydrogenase that is in Phase II clinical trials to treat acute myeloid leukemia; and ASLAN004, an interleukin 4/interleukin 13 receptor antibody for the treatment of severe atopic dermatitis and asthma. Further, it develops ASLAN005, an antibody that is in preclinical development targeting rece

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.547 - 2.571 2.571 - 2.586
Low: 2.134 - 2.162 2.162 - 2.179
Close: 2.148 - 2.193 2.193 - 2.221

Technical analysis

as of: 2020-01-24 4:29:44 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.96     One year: 3.35
Support: Support1: 1.98    Support2: 1.65
Resistance: Resistance1: 2.53    Resistance2: 2.87
Pivot: 2.38
Moving Average: MA(5): 2.50     MA(20): 2.31
MA(100): 1.88     MA(250): 2.83
MACD: MACD(12,26): 0.10     Signal(9): 0.11
Stochastic oscillator: %K(14,3): 49.81     %D(3): 62.40
RSI: RSI(14): 46.65
52-week: High: 8.18  Low: 0.35  Change(%): -38.8
Average Vol(K): 3-Month: 168030  10-Days: 70173

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ASLN has closed above bottom band by 28.3%. Bollinger Bands are 39.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 29 Mar 2019 14:24:54 +0000
Asian ADRs Move Higher in Friday Trading

Fri, 05 Apr 2019 14:29:38 +0000
Asian ADRs Move Higher in Friday Trading

Tue, 16 Apr 2019 14:23:21 +0000
Asian ADRs Move Lower in Tuesday Trading

Tue, 03 Dec 2019 14:15:10 +0000
Health Care Sector Update for 12/03/2019: BOLD, QHC, ASLN, JNJ, PFE, ABT, MRK, AMGN

Tue, 03 Dec 2019 02:47:50 +0000
KOD Dazzles, GLMD On Watch, DRIO Turns Heads…

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.99
Shares Float (M) 30.42
% Held by Insiders
% Held by Institutions 7.06
Shares Short (K) 419
Shares Short P. Month (K)

Stock Financials

EPS -0.855
Book Value (p.s.) 0.410
PEG Ratio
Profit Margin
Operating Margin -879.37
Return on Assets (ttm) -36.2
Return on Equity (ttm) -99.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.689
Qtrly Earnings Growth
Operating Cash Flow (M) -29.20
Levered Free Cash Flow (M) -19.22

Stock Valuations

P/E -2.55
P/E Growth Ratio -0.13
P/BV 5.32
P/S 24.22
P/CF -2.84

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.